Emerging role of long non-coding RNAs in cisplatin resistance
Open Access
- 1 May 2018
- journal article
- review article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 11, 3185-3194
Abstract
Cisplatin (CDDP) is one of the most commonly used chemotherapy drugs for the treatment of various cancers. Although platinum-based therapies are highly efficacious against rapidly proliferating malignant tumors, the development of CDDP resistance results in significant relapse as well as decreased overall survival rates, which is a significant obstacle in CDDP-based cancer therapy. Long non-coding RNAs (lncRNAs) are involved in cancer development and progression by the regulation of processes related to chromatin remodeling, transcription, and posttranscriptional processing. Emerging evidence has recently highlighted the roles of lncRNAs in the development of CDDP resistance. In this review, we discuss the roles and mechanisms of lncRNAs in CDDP chemoresistance, including changes in cellular uptake or efflux of a drug, intracellular detoxification, DNA repair, apoptosis, autophagy, cell stemness, and the related signaling pathways, aiming to provide potential lncRNA-targeted strategies for overcoming drug resistance in cancer therapy.Keywords
This publication has 86 references indexed in Scilit:
- The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 ExpressionPLOS ONE, 2013
- The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer CellPLOS ONE, 2013
- The functional role of long non-coding RNA in human carcinomasMolecular Cancer, 2011
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer DrugsMolecular Pharmacology, 2010
- Cellular Responses to Cisplatin‐Induced DNA DamageJournal of Nucleic Acids, 2010
- The BCL-2 protein family: opposing activities that mediate cell deathNature Reviews Molecular Cell Biology, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancersJournal of Clinical Investigation, 2007
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003